Mobile enhancement of motivation in schizophrenia: A pilot randomized controlled trial of a personalized text message intervention for motivation deficits.
Journal
Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
14
8
2020
medline:
25
2
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Motivation deficits remain an unmet treatment need in schizophrenia. Recent research has identified mechanisms underlying motivation deficits (i.e., impaired effort-cost computations, reduced future reward-value representation maintenance) that may be effective treatment targets to improve motivation. This study tested the feasibility and preliminary effectiveness of Mobile Enhancement of Motivation in Schizophrenia (MEMS), an intervention that leverages mobile technology to target these mechanisms with text messages. Fifty-six participants with a schizophrenia-spectrum disorder were randomized to MEMS (n = 27) or a control condition (n = 29). All participants set recovery goals to complete over 8 weeks. Participants in the MEMS group additionally received personalized, interactive text messages on their personal cellphones each weekday. Retention and engagement in MEMS were high: 92.6% completed 8 weeks of MEMS, with an 86.1% text message response rate, and 100% reported being satisfied with the text messages. Compared to participants in the control condition, the participants in the MEMS condition had significantly greater improvements in interviewer-rated motivation and anticipatory pleasure and attained significantly more recovery-oriented goals at 8 weeks. There were no significant group differences in purported mechanisms (performance-based effort-cost computations and future reward-value representations) or in self-reported motivation, quality of life, or functioning. Results demonstrate that MEMS is feasible as a brief, low-intensity mobile intervention that could effectively improve some aspects of motivation (i.e., initiation and maintenance of goal-directed behaviors) and recovery goal attainment for those with schizophrenia-spectrum disorders. More work is needed with larger samples and to understand the mechanisms of change in MEMS. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Identifiants
pubmed: 32790451
pii: 2020-59621-001
doi: 10.1037/ccp0000599
pmc: PMC9836765
mid: NIHMS1711690
doi:
Banques de données
ClinicalTrials.gov
['NCT03059771']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
923-936Subventions
Organisme : Indiana Clinical and Translational Sciences Institute
Organisme : Indiana Clinical and Translational Sciences Institute; Clinical Research Center
Organisme : NCATS NIH HHS
ID : UL1 TR001108
Pays : United States
Organisme : American Psychological Foundation
Organisme : NIMH NIH HHS
ID : T32 MH016259
Pays : United States
Références
Psychiatry Res. 1994 Jun;52(3):295-303
pubmed: 7991723
Arch Gen Psychiatry. 1997 Feb;54(2):159-65
pubmed: 9040284
Schizophr Res. 2007 Jul;93(1-3):253-60
pubmed: 17490858
Arch Gen Psychiatry. 1975 Mar;32(3):343-7
pubmed: 1115575
J Clin Psychiatry. 2016 Jun;77(6):764-71
pubmed: 27135986
Schizophr Res. 2008 Oct;105(1-3):95-104
pubmed: 18715756
Schizophr Bull. 2018 Aug 20;44(5):1010-1020
pubmed: 29939367
Psychiatr Rehabil J. 2016 Dec;39(4):364-367
pubmed: 27845533
J Abnorm Psychol. 2011 May;120(2):483-9
pubmed: 21171727
Schizophr Res. 2015 Dec;169(1-3):423-426
pubmed: 26391283
J Med Internet Res. 2010 Feb 17;12(1):e4
pubmed: 20164043
Schizophr Res. 2013 Dec;151(1-3):203-8
pubmed: 24183751
Schizophr Res. 2015 Feb;161(2-3):382-5
pubmed: 25487699
Schizophr Bull. 2014 Mar;40 Suppl 2:S107-16
pubmed: 24375459
J Exp Psychol Gen. 1999 Mar;128(1):78-87
pubmed: 10100392
Telemed J E Health. 2015 Feb;21(2):81-5
pubmed: 25474190
Clin Rehabil. 2009 Apr;23(4):352-61
pubmed: 19237435
PLoS One. 2012;7(2):e32595
pubmed: 22393420
Lancet Psychiatry. 2015 Nov;2(11):975-83
pubmed: 26363701
Schizophr Res. 2019 Apr;206:27-36
pubmed: 30577993
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
Schizophr Bull. 2015 Jul;41(4):892-9
pubmed: 25528757
Behav Processes. 2014 Sep;107:99-105
pubmed: 25139835
J Clin Psychiatry. 2003 Jun;64(6):663-7
pubmed: 12823080
Compr Psychiatry. 2013 Jul;54(5):568-74
pubmed: 23351831
Clin Psychol Rev. 2018 Apr;61:24-37
pubmed: 29751942
Psychiatry Res. 2012 Dec 30;200(2-3):89-95
pubmed: 22901437
Schizophr Bull. 2014 Nov;40(6):1244-53
pubmed: 24609454
BMJ Open. 2015 Nov 09;5(11):e008574
pubmed: 26553830
Schizophr Bull. 2015 Sep;41(5):1035-44
pubmed: 26089350
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
Arch Gen Psychiatry. 1977 Feb;34(2):159-63
pubmed: 843175
Schizophr Bull. 2015 Sep;41(5):1055-65
pubmed: 26209546
Pharmacol Biochem Behav. 1994 Sep;49(1):25-31
pubmed: 7816884
Br J Clin Psychol. 2016 Sep;55(3):332-47
pubmed: 26756621
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Br J Clin Psychol. 2010 Jun;49(Pt 2):259-74
pubmed: 19735607
J Nerv Ment Dis. 2010 Oct;198(10):715-21
pubmed: 20921861
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Am J Psychiatry. 1997 Apr;154(4 Suppl):1-63
pubmed: 9090368
Schizophr Bull. 2008 Sep;34(5):835-47
pubmed: 18591195
Schizophr Bull. 2012 May;38(3):414-25
pubmed: 22080492
Schizophr Bull. 2015 Mar;41(2):503-12
pubmed: 25053653
Am Psychol. 2002 Sep;57(9):705-17
pubmed: 12237980
J Ment Health. 2015;24(5):321-32
pubmed: 26017625
Schizophr Bull. 2015 Sep;41(5):1045-54
pubmed: 26142081
Psychol Serv. 2012 Aug;9(3):248-258
pubmed: 22545821
Behav Processes. 2005 May 31;69(2):173-87
pubmed: 15845306
Am J Psychiatry. 2013 Feb;170(2):165-72
pubmed: 23377637
Schizophr Res. 2015 Aug;166(1-3):304-9
pubmed: 26004693
Schizophr Res. 2016 Feb;170(2-3):278-84
pubmed: 26763628
PLoS One. 2009 Aug 12;4(8):e6598
pubmed: 19672310
Qual Life Res. 2011 Sep;20(7):1079-89
pubmed: 21290191
J Abnorm Psychol. 2007 May;116(2):268-78
pubmed: 17516760
Int J Clin Pract. 2008 Dec;62(12):1943-6
pubmed: 18795967
Psychiatry Res. 2011 May 15;187(1-2):24-9
pubmed: 21237516
Psychiatry Res. 2017 Jun;252:303-309
pubmed: 28301828
Community Ment Health J. 2008 Aug;44(4):283-8
pubmed: 18401713
JMIR Mhealth Uhealth. 2015 Feb 26;3(1):e20
pubmed: 25803705
J Neurosci. 2009 Jul 8;29(27):8839-46
pubmed: 19587291
J Abnorm Psychol. 2011 Nov;120(4):911-21
pubmed: 21875166
Schizophr Bull. 2009 Jul;35(4):798-806
pubmed: 18308717
J Psychiatr Res. 2013 Nov;47(11):1590-6
pubmed: 23992770
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Acta Psychiatr Scand. 2014 Oct;130(4):290-9
pubmed: 24850369
Schizophr Bull. 1984;10(3):388-98
pubmed: 6474101
Schizophr Res. 2014 Mar;153(1-3):209-13
pubmed: 24529609
Community Ment Health J. 2011 Dec;47(6):622-7
pubmed: 20676766
J Dual Diagn. 2014;10(4):197-203
pubmed: 25391277
Cogn Neuropsychiatry. 2007 May;12(3):213-21
pubmed: 17453902
Disabil Rehabil. 1994 Oct-Dec;16(4):223-6
pubmed: 7812023
Schizophr Bull. 2015 Mar;41(2):440-8
pubmed: 24375458
Stat Methods Med Res. 2016 Jun;25(3):1057-73
pubmed: 26092476
J Abnorm Psychol. 2014 May;123(2):387-97
pubmed: 24886012
Adm Policy Ment Health. 2013 Jul;40(4):340-3
pubmed: 22648635
Psychiatr Rehabil J. 2006 Fall;30(2):129-36
pubmed: 17076056
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683